Bringing business risk into sharp focus

Nat Biotechnol. 2012 Jan 9;30(1):30-2. doi: 10.1038/nbt.2081.
No abstract available

MeSH terms

  • Commerce / economics*
  • Commerce / legislation & jurisprudence
  • Commerce / organization & administration
  • Drug Industry / economics*
  • Drug Industry / legislation & jurisprudence
  • Drug Industry / organization & administration
  • Humans
  • Legislation, Drug*
  • Pharmaceutical Preparations / economics
  • Technology, Pharmaceutical / economics
  • Technology, Pharmaceutical / legislation & jurisprudence

Substances

  • Pharmaceutical Preparations